NEWSWORTHY
Japan approves world-first trial using iPS cells to treat spinal cord injuries
The health ministry on Monday approved the world's first clinical test in which artificially derived stem cells will be used to treat patients with spinal cord injuries. A team of researchers from Keio University, which filed a request for the test with the ministry, will ...
Osaka University approves iPS-linked clinical study for corneal damage
An Osaka University team Wednesday obtained broad approval for its plan to conduct a clinical study on a method to treat patients with a damaged cornea by transplanting cells made from induced pluripotent stem (iPS) cells from other people. The team will now file for ...
Keio researchers plan to treat spinal cord injuries with stem cells
Keio University is poised to conduct the world’s first treatment of patients who have sustained spinal cord injuries using induced pluripotent stem cells, sources said Tuesday.
Fujifilm plans iPS-based trials to treat complications from bone marrow transplants
Fujifilm Corp. aims to start clinical trials with artificially derived stem cells next year to prevent serious complications from bone marrow transplants used to treat leukemia, company officials say. The camera and medical equipment maker, which has been expanding its pharmaceuticals business, will apply for ...
Japan OKs first clinical study of iPS cell-based heart treatment
The world’s first clinical study for treating heart failure with so-called iPS cells could start in Japan in the coming months after the health ministry approved a plan by Osaka University.
Putin's turf war with Telegram escalates as Russia blocks IPs
Russia's communications regulator blocked some Alphabet Inc. internet addresses, blaming the U.S. owner of Google for helping Pavel Durov's Telegram Messenger LLP service evade government blocking. "Google hasn't complied with Roskomnadzor requests and, despite a court ruling, keeps allowing Telegram Messenger to use its IP ...
Osaka University OKs world's first test of iPS-cell-based heart failure treatment
A Japanese team of physicians won approval Friday from an Osaka University panel for its plan to carry out the world's first clinical study for treating heart failure with sheets of cardiac muscle cells created from so-called iPS cells. Given the panel's approval for the ...
iPS-based heart treatment moves closer to clinical study as Osaka University panel gives approval
A screening committee at Osaka University has broadly approved a plan to perform a clinical study on the treatment of severe heart disease using induced pluripotent stem (iPS) cells. The group behind the research, led by professor Yoshiki Sawa, is set to submit the plan ...
Nobel winner Shinya Yamanaka to donate salary after iPS research scandal at Kyoto University
Nobel laureate Shinya Yamanaka, who heads a research institute for induced pluripotent stem cells at Kyoto University, is considering donating his salary to the facility to take responsibility for data fabrication in a paper by one of its researchers, sources have said. The donation would ...
Unstable work seen as a factor as Kyoto University admits iPS researcher falsified data in paper
Experts say unstable employment conditions faced by scientists are behind the string of research-related scandals in the nation.
First serious adverse reaction to iPS-derived retinal cell transplant reported
A patient who underwent transplant surgery using retinal cells derived from so-called iPS cells from another person has suffered a swollen retina, the team that carried out the world's first clinical trial of the procedure said Tuesday. It is the first time a patient has ...
Japanese scientists find new drug combo that may be key to treating Alzheimer's
A team of Japanese researchers has found a new drug combination that reduces amyloid beta protein, believed to play a key role in causing Alzheimer's disease, by using stem cells derived from patients, Kyoto University announced Tuesday. The scientists believe their findings, published in the ...
